Resverlogix Corp Stock Today
| RVX Stock | CAD 0.06 0.01 8.33% |
Performance0 of 100
| Odds Of DistressOver 67
|
Resverlogix Corp is selling at 0.055 as of the 1st of December 2024; that is 8.33% down since the beginning of the trading day. The stock's open price was 0.06. Resverlogix Corp has more than 67 % chance of experiencing financial distress in the next few years of operation. It also generated negative returns for investors over the last 90 days. Equity ratings for Resverlogix Corp are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 1st of November 2024 and ending today, the 1st of December 2024. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Resverlogix Corp. operates as a late-stage clinical biotechnology company. It is developing apabetalone , a small molecule selective bromodomain and extra-terminal inhibitor that is in Phase III clinical trials for patients with cardiovascular, chronic kidney, end-stage renal, neurodegenerative, fabry, peripheral artery, and other orphan diseases, as well as diabetes mellitus. The company has 280.65 M outstanding shares of which 50.44 K shares are at this time shorted by private and institutional investors with about 1.32 days to cover all short positions. More on Resverlogix Corp
Moving against Resverlogix Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Resverlogix Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Resverlogix Corp's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Resverlogix Corp or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| CEO | Donald McCaffrey | ||||
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) | ||||
Resverlogix Corp's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Resverlogix Corp's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit. | |||||
Debt LevelsResverlogix Corp can leverage the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Resverlogix Corp's financial leverage. It provides some insight into what part of Resverlogix Corp's total assets is financed by creditors.
| |||||
Resverlogix Corp (RVX) is traded on Toronto Exchange in Canada and employs 4 people. Resverlogix Corp is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Micro-Cap' category with a current market capitalization of 15.44 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Resverlogix Corp's market, we take the total number of its shares issued and multiply it by Resverlogix Corp's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Resverlogix Corp operates under Biotechnology sector and is part of Health Care industry. The entity has 280.65 M outstanding shares of which 50.44 K shares are at this time shorted by private and institutional investors with about 1.32 days to cover all short positions.
Resverlogix Corp has accumulated about 7.69 M in cash with (2.61 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.04.
Check Resverlogix Corp Probability Of Bankruptcy
Ownership AllocationResverlogix Corp owns a total of 280.65 Million outstanding shares. Resverlogix Corp has significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.
Check Resverlogix Ownership Details
Resverlogix Corp Risk Profiles
Although Resverlogix Corp's alpha and beta are two of the key measurements used to evaluate Resverlogix Corp's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 3.92 | |||
| Standard Deviation | 7.4 | |||
| Variance | 54.81 | |||
| Risk Adjusted Performance | (0.04) |
Resverlogix Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Resverlogix Corp without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
| All Next | Launch Module |
Other Information on Investing in Resverlogix Stock
Resverlogix Corp financial ratios help investors to determine whether Resverlogix Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Resverlogix with respect to the benefits of owning Resverlogix Corp security.